Terumo BCT
Clinical trials sponsored by Terumo BCT, explained in plain language.
Now part of
Terumo Corporation
TRUMY
OTC
Develops blood component, therapeutic apheresis, and cell therapy technologies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.